EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+2.43%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$1.21B
(-3.2%)
Cap. Flow
-$36.6M
Cap. Flow
% of AUM
-3.03%
Top 10 Holdings %
Top 10 Hldgs %
49.32%
Holding
122
New
19
Increased
31
Reduced
32
Closed
17
Top Buys
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$60.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$27.8M |
| 3 |
Labcorp
LH
|
$26M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$24.5M |
| 5 |
Masimo
MASI
|
$18.1M |
Sector Composition
| 1 | Healthcare | 93.47% |
| 2 | Industrials | 1.55% |
| 3 | Technology | 0.08% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
51
DELISTED
NEVRO CORP.
NVRO
| $5.36M | 0.34% | +66,074 | New | +$5.36M |
|
52
Zentalis Pharmaceuticals
ZNTL
$122M
| $5.31M | 0.34% | +63,163 | New | +$5.31M |
|
53
Merck
MRK
$210B
| $5.03M | 0.32% | +19,456 | New | +$5.03M |
|
54
Aurinia Pharmaceuticals
AUPH
$1.58B
| $4.61M | 0.29% | +201,384 | New | +$4.61M |
|
55
Viridian Therapeutics
VRDN
$1.5B
| $3.85M | 0.25% | 194,589 +34,589 | +22% | +$684K |
|
56
Maravai LifeSciences
MRVI
$350M
| $3.68M | 0.24% | 87,795 -240,015 | -73% | -$10.1M |
|
57
Intuitive Surgical
ISRG
$170B
| $3.53M | 0.23% | 9,825 +6,680 | +212% | +$2.4M |
|
58
DexCom
DXCM
$29.5B
| $3.44M | 0.22% | 6,401 | – | – |
|
59
Puma Biotechnology
PBYI
$254M
| $3.4M | 0.22% | 1,117,898 +719,958 | +181% | +$2.19M |
|
60
Lexicon Pharmaceuticals
LXRX
$400M
| $3.14M | 0.2% | 797,694 -75,000 | -9% | -$296K |
|
61
Agilent Technologies
A
$35.7B
| $3.1M | 0.2% | 19,431 +771 | +4% | +$123K |
|
62
CureVac
CVAC
$1.21B
| $2.92M | 0.19% | +85,017 | New | +$2.92M |
|
|
GRTS
63
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.19M | 0.14% | +170,125 | New | +$2.19M |
|
|
MRTX
64
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.18M | 0.14% | 14,840 +5,485 | +59% | +$805K |
|
|
KRTX
65
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.09M | 0.13% | 15,934 -9,066 | -36% | -$1.19M |
|
|
AUTL
66
Autolus Therapeutics
AUTL
$399M
| $2.08M | 0.13% | 401,540 +3,466 | +0.9% | +$18K |
|
67
Sanofi
SNY
$121B
| $1.94M | 0.12% | 38,672 -220,456 | -85% | -$11M |
|
68
Establishment Labs
ESTA
$1.2B
| $1.7M | 0.11% | +25,137 | New | +$1.7M |
|
|
SRGA
69
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.37M | 0.09% | 1,918,743 -1,589,793 | -45% | -$1.14M |
|
|
ADAP
70
Adaptimmune Therapeutics
ADAP
$15.6M
| $1.31M | 0.08% | 348,716 -96,171 | -22% | -$361K |
|
71
Repligen
RGEN
$6.88B
| $1.21M | 0.08% | 4,584 +182 | +4% | +$48.2K |
|
|
TECX
72
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $1.17M | 0.08% | 304,989 -54,491 | -15% | -$210K |
|
73
Myomo
MYO
$39.7M
| $1.03M | 0.07% | 150,000 | – | – |
|
|
VCRA
74
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $971K | 0.06% | +14,970 | New | +$971K |
|
75
Milestone Pharmaceuticals
MIST
$156M
| $964K | 0.06% | 147,165 +33,568 | +30% | +$220K |
|